The Triple-Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol.

Frédéric PouliotJean-Mathieu BeauregardFred SaadDominique TrudelPatrick O RichardÉric TurcotteÉtienne RousseauStephan ProbstWassim KassoufMaurice AnidjarFélix Camirand LemyreGuillaume F BouvetBertrand NeveuAmélie TétuBrigitte Guérin

Published in: BJU international (2021)

This study will add novel, biologically relevant dimensions to molecular imaging: the non-invasive detection of inter-metastatic heterogeneity and transdifferentiation to neuroendocrine prostate cancer by using a multi-tracer PET/CT strategy to further personalise the care of patients with mCRPC.

Keyphrases

prostate cancer
pet ct
positron emission tomography
radical prostatectomy
squamous cell carcinoma
small cell lung cancer
study protocol
healthcare
randomized controlled trial
pet imaging
palliative care
clinical trial
single cell
quality improvement
chronic pain
label free
real time pcr